62° AFI Symposium – Dr Pontello and Regola’s interview

During the Symposium session, attention will be paid to what factors are most likely to affect the prevention of contamination and cross-contamination

Quality Risk Management, what changes with the new ICHQ9

The new edition of the guideline resolves some of the critical issues that emerged in the practice of using Quality Risk Management

Challenges for QP: imports of medicines, vaccines and new technologies

During the second part of the XV Qualificate People meeting, settled by AFI, the main themes have been imports of medicines, challenges due to new technologies and, of course, vaccines

The approach of Spai to pharmaceutical validation

Fabio Farneti, owner of Spai srl, walks us through the details of the pharmaceutical validation approach adopted by his company
Making Community